PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy
Background The enzymatic conversion of arginine to citrulline is involved in gene and protein regulation and in alerting the immune system to stressed cells, including tumor cells. Nucleophosmin (NPM) is a nuclear protein that plays key roles in cellular metabolism including ribosome biogenesis, mRN...
Saved in:
| Main Authors: | Victoria A Brentville, Rachael L Metheringham, Ian Daniels, Peter Symonds, Katherine W Cook, Mohamed Gijon, Lindy G Durrant, Ruhul H Choudhury, Samantha J Paston |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-02-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/2/e003526.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy
by: Wei Xue, et al.
Published: (2021-07-01) -
Epitope-Based Chicken-Derived Novel Anti-PAD2 Monoclonal Antibodies Inhibit Citrullination
by: Masayoshi Aosasa, et al.
Published: (2021-01-01) -
Prevalence of Classification of Nucleophosmin 1 Gene Mutations in Iraqi Cohort of Acute Myeloid Leukemia
by: Shurooq A. Lafta, et al.
Published: (2025-01-01) -
Citrullination of NF‐κB p65 by PAD2 as a Novel Therapeutic Target for Modulating Macrophage Polarization in Acute Lung Injury
by: Xin Yu, et al.
Published: (2025-05-01) -
HTLV-I Basic Leucine Zipper Factor (sHBZ) Actively Associates with Nucleophosmin (B23) in the Nucleolus
by: Nahid Moghadam, et al.
Published: (2025-05-01)